Navigation Links
The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February
Date:2/7/2010

The Ken Blanchard Executive MBA is a 12-month MBA program focused on executive leadership. Delivered in a blended learning format that combines the convenience of online learning and the power of three in-person residencies, the Ken Blanchard EMBA attracts student leaders from all over the US.

Phoenix, AZ (PRWEB) February 5, 2010 -- The Ken Blanchard Executive MBA is a 12-month MBA program focused on executive leadership. Delivered in a blended learning format that combines the convenience of online learning and the power of three in-person residencies, the Ken Blanchard EMBA attracts student leaders from all over the US. The Ken Blanchard Executive MBA Program's next cohort begins in February and offers the unique opportunity to build lasting relationships and gain the tools and perspectives needed to successfully engage in self and organizational leadership


Participants move through the program in synchronous groups- or cohorts- a unique system that creates strong bonds and enhances learning because students study and grow as a cohesive unit.

"We have wonderful faculty and great content," said Taylor Carr, Director of the Ken Blanchard Executive MBA Program, "but considering the varied backgrounds of our students, some of the key learning always comes from in-class interaction. What's really powerful is going through the process of synthesizing thought and then sharing that with others."

The Ken Blanchard Executive MBA Program's next cohort begins in February and offers the unique opportunity to build lasting relationships and gain the tools and perspectives needed to successfully engage in self and organizational leadership. Dr. Blanchard and top trainers from the Blanchard Companies teach the four-day residencies, along with faculty from
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Blanchard Schaefer Advertising & Public Relations Wins Healthcare Advertising Awards
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. Align Technology Executive to Present at Upcoming Financial Conferences
4. Mediware Names Thomas K. Mann Chief Executive Officer
5. PRA International Adds Dr. Susan Stansfield as Executive Vice President
6. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
7. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
10. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
11. Frances Decker Named Mid-Atlantic Region Sales Executive for AllOne Health Management Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 
(Date:10/30/2014)... TX (PRWEB) October 30, 2014 ... released today its 2014 third quarter infection rates ... Texas boasted infection rates of only two percent ... patient satisfaction scores exceeding 98 percent. , “We ... quarter, which included rising satisfaction scores,” said Robert ...
(Date:10/30/2014)... News) -- Scientists who used stem cells to create ... could provide a new way to learn more about ... team used human pluripotent stem cells -- which can ... to grow the functional miniature stomachs, to study infection ... of ulcers and stomach cancer. The miniature stomachs ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Many U.S. colleges ... even though tanning increases the risk for skin ... young adults, particularly white women, so colleges should ... the researchers said. "Public health efforts are ... awareness of the harms that indoor tanning poses ...
(Date:10/30/2014)... A new vaccine that could help prevent some cases ... U.S. Food and Drug Administration on Wednesday. Trumenba ... 10 and 25 from invasive meningococcal disease caused by ... bacteria can infect the bloodstream (sepsis) and the lining ... a leading cause of bacterial meningitis, and infection can ...
(Date:10/29/2014)... and even non-invasive technologies is increasing in the medical ... out a range of operative procedures using keyhole surgery ... scars as a result. Similar opportunities are now becoming ... – instead of using injections or probes to deliver ... them via a plaster which continuously, gently and painlessly ...
Breaking Medicine News(10 mins):Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2Health News:FDA Approves New Vaccine to Protect Against Meningitis 2Health News:Gentle caffeine boost for premature babies 2
... ... ... company that launched the first FDA cleared Fourier/spectral domain OCT in the US, announced its ... , ,“Following our 19% revenue growth in 2009 over 2008, we expected the economy and ...
... Emergency services double ... ... announced ambitious plans to add a second inpatient tower to meet what has become an enormous ... beds, more emergency care and more jobs to the Anschutz Medical Campus and the state., , ...
... ... inspire, motivate and empower members of the healthcare team and the patients and family members ... calling for entries now, with winners announced later this year. , ... Rockville, MD (PRWEB) May 24, 2010 -- Dorland ...
... PLoS ONE, Massachusetts General Hospital (MGH) ... individuals unconsciously distribute their preferences regarding approaching or ... appear to meet the strict criteria used to ... if confirmed in future studies, could potentially be ...
... patients with transformed lymphoma showed "remarkable" response to lenalidomide, ... international study, involving 24 medical centers in the United ... Society of Clinical Oncology ( http://www.asco.org/ ) annual meeting ... of patients with transformed lymphoma treated with lenalidomide responded ...
... triggers the need for a night,s rest may be the ... Brain injuries can disrupt the body,s production of the hormone ... , "We,ve known that people often have problems with sleep ... the exact causes of these problems," study author Shantha Rajaratnam ...
Cached Medicine News:Health News:Optovue Q1 2010 Revenue Up 57% Over Same Quarter 2009 2Health News:,University of Colorado Hospital Moving Forward with $400 Million Expansion, 2Health News:,University of Colorado Hospital Moving Forward with $400 Million Expansion, 3Health News:Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries 2Health News:Study finds 'law-like' patterns in human preference behavior 2Health News:Study finds 'law-like' patterns in human preference behavior 3Health News:Study identifies promising treatment for aggressive lymphoma 2Health News:Brain Injuries May Lead to Sleep Woes 2
(Date:10/30/2014)... 2014 Molecular Profiles Ltd., a subsidiary of ... Maryland -based Xceleron have announced a ... clinical development that will be launched at AAPS in ... This partnership extends Molecular Profiles, new ROADMAP to ... this month. The company also has complementary collaborations in ...
(Date:10/30/2014)... 30, 2014  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced an upcoming presentation ... candidate, aldoxorubicin.  The presentation, titled, "Drug Conjugates Bind ... given by Sant P. Chawla , M.D., ... principal investigator of the Company,s ongoing global, pivotal ...
(Date:10/30/2014)... October 30, 2014 , ... LGG contribuye a adquirir tolerancia a la proteína ... la proteína de la leche de la vaca (APLV) ... infancia. Hasta ahora, la APLV se trataba eliminando ... ha demostrado que es posible adquirir tolerancia oral ...
Breaking Medicine Technology:Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3
... Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO ) today reported ... Total revenue was $2.4 million and $5.5 million for the three ... $2.5 million for the same periods in 2010. Total ... 2011, were $7.6 million and $15.0 million as compared to $6.1 ...
... 2011 CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI ... the three months ended June 30, 2011. ... drug candidate, MF101, or Menerba™, during the past quarter, delivering ... and Chief Executive Officer. "We have completed the tasks which ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 9Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 10Inovio Pharmaceuticals Reports 2011 Second Quarter Financial Results 11CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 2CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 3CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 4CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 5
... Ankle Orthosis enables the clinician to ... ankle joint to control muscle imbalance ... a pair of bilateral turnbuckles, controlling ... Simply adjust the turnbuckle to gradually ...
... Protection,Protects the heel while maintaining the ankle ... contact with a soft, cushioning AliPlast™ foam ... and liner cradles the heel in a ... change position freely in bed from side-lying ...
... Pediatric Ankle Cryo/Cuff is specifically designed to ... Using a combination of controlled compression and ... pain. The Pediatric Ankle Cryo/Cuff is ideal ... episodes in hemophilia.,The Pediatric Ankle Cryo/Cuff is ...
SCD Sequential Compression System Intermittent Pneumatic Compression...
Medicine Products: